title: Surgical management of invasive pulmonary fungal infection in hematology patients.
abstract: BACKGROUND
  The purpose of this study was to analyze our institutional results with pulmonary resection in neutropenic patients with hematologic malignancies and suspected invasive pulmonary fungal infections.
  
  
  METHODS
  We performed a retrospective medical record review of 25 immunocompromised patients with hematologic malignancies who underwent pulmonary resection between 2000 and 2007. We analyzed preoperative diagnostic technique, degree of pulmonary resection, and postoperative morbidity and mortality to determine whether surgery is a viable treatment option in this subset of patients.
  
  
  RESULTS
  Twenty-three of 25 patients had a minithoracotomy compared with 2 who had video-assisted thorascopic surgery resection only. Thirteen had wedge resections, 9 had lobectomies, and 3 had segmentectomies. Early surgical morbidity was 2 of 25, involving 1 pneumothorax and 1 empyema. In-hospital mortality was 2, with 1 death primarily related to surgery. Median survival was 342 days, and survival was significantly better in patients with only one lesion. No patient experienced late recurrence of invasive pulmonary fungal infection. Resected pulmonary tissue also provided the best chance for a proven diagnosis in 19 of 25 (76%).
  
  
  CONCLUSIONS
  This study confirms that pulmonary resection in high-risk immunocompromised patients with suspected invasive fungal infection can be carried out with excellent operative morbidity and mortality.
authors.affiliation: Department of Cardiothoracic Surgery, The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Theodore
authors.forename: Matthew
authors.initials: M
authors.lastname: Liava'a
authors.forename: Phillip
authors.initials: P
authors.lastname: Antippa
authors.forename: Rochelle
authors.initials: R
authors.lastname: Wynne
authors.forename: Andrew
authors.initials: A
authors.lastname: Grigg
authors.forename: Monica
authors.initials: M
authors.lastname: Slavin
authors.forename: James
authors.initials: J
authors.lastname: Tatoulis
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D004322:Drainage / Q000379:methods; D019337:Hematologic Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D006801:Humans; D008172:Lung Diseases, Fungal / Q000150:complications / Q000000981:diagnostic imaging / Q000401:mortality / Q000601:surgery*; D009181:Mycoses / Q000401:mortality / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate; D017741:Survivors; D020775:Thoracic Surgery, Video-Assisted / Q000379:methods* / Q000401:mortality; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents